HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Abdullah A Alqasem Selected Research

TG 003

12/2021CDC2-like (CLK) protein kinase inhibition as a novel targeted therapeutic strategy in prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Abdullah A Alqasem Research Topics

Disease

1Neoplasms (Cancer)
12/2021
1Prostatic Neoplasms (Prostate Cancer)
12/2021

Drug/Important Bio-Agent (IBA)

1benzothiazoleIBA
12/2021
1TG 003IBA
12/2021
1Phosphotransferases (Kinase)IBA
12/2021
1Protein Kinases (Protein Kinase)IBA
12/2021